Here are three takeaways:
1. The collaboration between the two companies aimed at developing next generation spinal fusion integrated products.
2. Under the new collaboration, the companies aim to combine Bone Therapeutics’ ALLOB cells with Kasios’ spinal fusion cage containing a 3D-bioprinted synthetic matrix.
3. The combined product aims to simplify the surgical procedure and accelerate the fusion process.
More articles on devices:
Amedica, J&J, Stryker & more: 18 key notes
Smith & Nephew CEO Olivier Bohuon has cancer—But will remain on the job
North America leads global neurosurgery market: 5 points
